The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Ixico signs new contract for Phase 2 Huntington's Disease clinical trial
Dec 10, 2024•over 1 year ago
Contract Type
contract
LondonBiotechnologyHealth CareMedical
Description
Ixico has secured a new contract with a US-based client to provide imaging services for a Phase 2 Huntington's Disease clinical trial, with a contract value worth more than £500,000 over approximately two and a half years. This contract reinforces Ixico's expertise in supporting neurodegenerative disease trials and aligns with its strategic pillars for expansion and growth.
Company Information
Company
Ixico PLC
Location
London, England, United Kingdom
About
Ixico PLC is a London-based medical analytics company focused on accelerating the growth and global commercial reach of neurology technology platforms, addressing unmet clinical needs in neurological diseases, and developing and scaling product offerings across areas of drug development.
LondonBiotechnologyHealth CareMedical